Proteomics

Dataset Information

0

Label-free whole cell proteomics for oncogene cell lines

ABSTRACT: Label-free whole cell proteomics was performed for the following cell lines: LHS-PREC engineered to overexpress MYC or EV; P4936 overexpressing MYC on a tetracycline-repressible promotor; MCF10A cells expressing signal transduction oncogenes AKT, BRAF, EGFR, HER2, KRAS, MEK; KP4 and PSN1 PDAC cell lines vs HPDE normal pancreatic cell; PDX-derived osteosarcoma cell lines with MYC amplification vs hFOB cell

INSTRUMENT(S): Q Exactive Plus

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Pancreatic Ductal Cell, B Cell, Osteoblast, Breast, Cell Culture, Prostate Epithelium

DISEASE(S): Osteosarcoma,Prostate Cancer,Burkitt Lymphoma,Pancreatic Cancer

SUBMITTER: Paige Solomon  

LAB HEAD: Jim Wells

PROVIDER: PXD033373 | Pride | 2022-08-11

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
20180506_GMW_Wells_MCF_AKT_Depleted_1.raw Raw
20180506_GMW_Wells_MCF_AKT_Depleted_2.raw Raw
20180506_GMW_Wells_MCF_AKT_Depleted_3.raw Raw
20180506_GMW_Wells_MCF_Braf_Depleted_1.raw Raw
20180506_GMW_Wells_MCF_Braf_Depleted_2.raw Raw
Items per page:
1 - 5 of 122
altmetric image

Publications

Discovery Proteomics Analysis Determines That Driver Oncogenes Suppress Antiviral Defense Pathways Through Reduction in Interferon-β Autocrine Stimulation.

Solomon Paige E PE   Kirkemo Lisa L LL   Wilson Gary M GM   Leung Kevin K KK   Almond Mark H MH   Sayles Leanne C LC   Sweet-Cordero E Alejandro EA   Rosenberg Oren S OS   Coon Joshua J JJ   Wells James A JA  

Molecular & cellular proteomics : MCP 20220518 7

Since the discovery of oncogenes, there has been tremendous interest to understand their mechanistic basis and to develop broadly actionable therapeutics. Some of the most frequently activated oncogenes driving diverse cancers are c-MYC, EGFR, HER2, AKT, KRAS, BRAF, and MEK. Using a reductionist approach, we explored how cellular proteomes are remodeled in isogenic cell lines engineered with or without these driver oncogenes. The most striking discovery for all oncogenic models was the systemati  ...[more]

Similar Datasets

Proteomics Oncogene Regulated Release of Extracellular Vesicles
2021-04-16 | MSV000087219 | MassIVE
Transcriptomics Transcriptomics indicate nuclear division and cell adhesion not recapitulated in MCF7 and MCF10A compared to luminal A breast tumours
2022-11-08 | GSE208731 | GEO
Transcriptomics RNA-seq of MCF10A cells stably expressing empty vector, GFP, miR-105, or MYC
2018-02-11 | GSE106502 | GEO
Methylation profiling DNA methylation analysis of pancreatic cancer and non-malignant pancreas cell lines
2012-11-01 | GSE40097 | GEO
Transcriptomics RNA expression analysis of pancreatic cancer and non-malignant pancreas cell lines
2012-11-01 | GSE40098 | GEO
Proteomics Shotgun proteomic analysis of pancreatic cancer cell lines vs. normal epithelial ductal pancreatic cells
2020-02-07 | MSV000084935 | MassIVE
Transcriptomics A novel post-translational mechanism controlling the oncogenic activity of c-Myc is enhanced in poor outcome breast cancer
2014-05-28 | E-GEOD-33776 | biostudies-arrayexpress
Proteomics Proteome and secretome analysis of pancreatic cancer cell lines vs. normal epithelial ductal pancreatic cells
2021-10-21 | MSV000088250 | MassIVE
Transcriptomics Expression data from pancreatic cancer cell lines
2010-04-02 | GSE21163 | GEO
Transcriptomics Gene expression from human B-lymphocytes (P493-6)
2011-09-19 | GSE32219 | GEO